Vroom, Inc. (NASDAQ: VRM) shares are trading lower in Monday's after-hours session after the company announced it is discontinuing its operations and winding down its used
The Travel Agency: A Cannabis Store and Curaleaf Holdings Inc. (OTC: CURLF) are opening new cannabis shops in New York, enhancing the state's legal cannabis retail presence.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday.
The Dow traded up 0.27% to 37,967.81 while the NASDAQ rose 0.31% to 15,358.70. The S&P 500 also rose, gaining, 0.23% to 4,850.71.
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session.
B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2.
CommScope shares dipped 6.9% to $2.2150 on Monday.
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday.
The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30% to 15,356.67. The S&P 500 also rose, gaining, 0.25% to 4,851.78.
U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday.
Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will acquire the company in an all-equity transaction valued at roughly $7.3 billion.
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday.
Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose 0.71% to 15,420.00. The S&P 500 also rose, gaining, 0.49% to 4,863.49.
The Dow Jones index closed higher by around 400 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Shares of Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose sharply in today’s pre-market trading after the company announced an agreement to divest ophthalmology franchise to Sandoz in $170 million upfront all cash deal.